Filing Flows › PTC Therapeutics (PTCT) › Net product revenue revenue
PTC Therapeutics (PTCT) Net product revenue revenue by quarter
PTC Therapeutics' Net product revenue revenue was $276M in Q3 2026 (third quarter 2026), +16% from Q2 2026. Over the last 5 quarters it ranged from $118M (Q2 2025) to $276M (Q3 2026).
| Quarter | Net product revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $276M | +16% | +110% |
| Q2 2026 | $239M | +6% | +102% |
| Q1 2026 | $226M | +72% | — |
| Q3 2025 | $131M | +11% | — |
| Q2 2025 | $118M | — | — |
Q3 2026 at a glance
PTC Therapeutics, Q3 2026: revenue $358M (+70% year over year), operating margin 7.0%, net loss $51.7M, operating cash flow −$25.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is PTC Therapeutics' Net product revenue revenue?
PTC Therapeutics' Net product revenue revenue was $276M in Q3 2026 (third quarter 2026), +16% from Q2 2026.
How has PTC Therapeutics' Net product revenue revenue changed?
Over the last 5 quarters it ranged from $118M (Q2 2025) to $276M (Q3 2026).